A prospective clinical study for a rectal CRM automatic detection system based on Faster-RCNN

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023324

Enrollment

Unknown

Registered

2019-05-22

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

1:Ai diagnostic imaging

2:Conventional imaging diagnosis

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Rectal cancer patients aged 40-70 years; 2. The patient has received high-resolution MRI; 3. The patient was treated for the first time without surgery, radiotherapy or chemotherapy; 4. signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with diabetes mellitus, rheumatic immune diseases, severe heart, brain, kidney and other systemic diseases; 2. The imaging confirmed the presence of pelvic organ abnormality; 3. other pelvic surgery was performed.

Design outcomes

Primary

Measure	Time frame
Postoperative pathological results;	—

Secondary

Measure	Time frame
Quality of life after treatment;clinical prognosis;lifetime;	—

Countries

China

Contacts

Public ContactLu Yun

Affiliated Hospital of Qingdao University

cloudylucn@126.com+86 18661802231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026